Our medicines
We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. We are investing billions in Research and Development (R&D), which includes the discovery and development of new medicines.
Below is a list of our company's marketed products. Any linked documents and websites are intended only for residents 18 years or older, as the availability of medicines and the indications for which they are approved can vary with country and region.
Please refer to the full prescribing information approved by the relevant governmental authority of the country where you are located and consult your physician for professional medical advice and services.
Key products (Australia)
AZACTAM® (aztreonam)
BARACLUDE® (entecavir)
CAMZYOS® (mavacamten)
CEENU® (lomustine)
ELIQUIS® (apixaban)
EMPLICITI® (elotuzumab)
EVOTAZ® (atazanavir & cobicistat)
ISTODAX® (romidepsin)
MONOPRIL® (fosinopril sodium)
ONUREG® (azacitidine)
OPDIVO® (nivolumab)
OPDUALAG™ (nivolumab/ relatlimab)
ORENCIA® (abatacept)
POMALYST® (pomalidomide)
REVLIMID® (lenalidomide)
REYATAZ® (atazanavir sulfate)
SOTYKTU™ (deucravacitinib)
SPRYCEL® (dasatinib)
THALOMID® (thalidomide)
VIDAZA® (azacitidine)
YERVOY™ (ipilimumab)
ZEPOSIA™ (ozanimod)
Consumer medicine information
Consumer medicine information, or CMI, provides clear, easy-to-understand information to consumers and their carers about how to use their medicines.
A CMI will outline:
- What the medicine is used for
- How it works
- How to use it
- Its ingredients
- Its known side effects
- Whether it has any interaction with other medicines
For more information, please contact your doctor or pharmacist.
Consumer Medicine Information leaflets for key Bristol Myers Squibb products available in Australia are included on this page. Importantly, this information is intended for use in Australia only and does not replace advice from a healthcare professional.